Concepedia

Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial

Dieter Volc, Werner Poewe, Alexandra Kutzelnigg, Petra Lührs, Caroline Thun-Hohenstein, Achim Schneeberger, Gergana Galabova, Nour K. Majbour, Nishant N. Vaikath, Omar M. A. El‐Agnaf,

The Lancet Neurology · 2020 · 145 citations · 17 references

DOI

Concepts

References

17

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Andrew Hughes, S. E. Daniel, Linda Kilford et al. · Journal of Neurology Neurosurgery & Psychiatry · 1992 · 10.4K citations · Full text

, , +15

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

Christopher G. Goetz, Barbara C. Tilley, Stephanie R. Shaftman et al. · Movement Disorders · 2008 · 7.5K citations · Full text

, , +16

Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism

Stanley B. Prusiner, Amanda L. Woerman, Daniel A. Mordes et al. · Proceedings of the National Academy of Sciences · 2015 · 706 citations · Full text

, , +17

Effects of α-Synuclein Immunization in a Mouse Model of Parkinson’s Disease

Eliezer Masliah, Edward Rockenstein, Anthony Adame et al. · Neuron · 2005 · 536 citations · Full text

, , +15

Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease

Eliezer Masliah, Edward Rockenstein, Michael Mante et al. · PLoS ONE · 2011 · 422 citations · Full text

, , +17